Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL−1

Rabe, K. F., Pavord, I. D., Castro, M., Wechsler, M. E., Daizadeh, N., Kapoor, U., … Jacob-Nara, J. A. (2022, June 1). Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL−1. European Respiratory Journal. European Respiratory Society. https://doi.org/10.1183/13993003.02577-2021